| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |